Agios Pharm (AGIO) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Historical revenue and profitability trends for Agios Pharm
The chart above illustrates Agios Pharm's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Agios Pharm's business.
How efficiently Agios Pharm converts revenue into profit
Profit margins reveal how much of each dollar of revenue Agios Pharm retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Agios Pharm to continue growing earnings in the coming year. The consensus analyst rating is 4 based on 9 analysts.
Based on our comprehensive analysis, Agios Pharm (AGIO) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Agios Pharm's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Agios Pharm stacks up against similar companies
Explore growth analysis for top stocks
Related: AGIO Valuation, AGIO Dividend, AGIO Financial Health
Compare: AGIO vs AAPL, AGIO vs MSFT, AGIO vs GOOGL